3-MMC
Selected indexed studies
- The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review. (Forensic Sci Int, 2019) [PMID:30572220]
- Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands: A systematic narrative review of the prevalence and risks. (Int J Drug Policy, 2025) [PMID:40876068]
- Porous, crystalline, covalent organic frameworks. (Science, 2005) [PMID:16293756]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Analytical Characterization of 3-MeO-PCP and 3-MMC in Seized Products and Biosamples: The Role of LC-HRAM-Orbitrap-MS and Solid Deposition GC-FTIR. (2020) pubmed
- The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review. (2019) pubmed
- Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands: A systematic narrative review of the prevalence and risks. (2025) pubmed
- Porous, crystalline, covalent organic frameworks. (2005) pubmed
- NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users. (2023) pubmed
- 3-Methylmethcathinone (3-MMC) Poisonings: Acute Clinical Toxicity and Time Trend Between 2013 and 2021 in the Netherlands. (2022) pubmed
- In vitro biotransformation of 3-methylmethcathinone (3-MMC) through incubation with human liver microsomes and cytosol and application to in vivo samples. (2024) pubmed
- Low to moderate doses of 3-methylmethcathinone (3-MMC) produce analgesic effects in healthy volunteers: a proof of principle study with a designer drug. (2025) pubmed
- Chemsex/slamsex-related intoxications: A case report involving gamma-hydroxybutyrate (GHB) and 3-methylmethcathinone (3-MMC) and a review of the literature. (2021) pubmed
- Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study. (2025) pubmed